Abstract:In mammals, oleic acid (OA) induces pulmonary edema (PE), which can initiate acute lung injury (ALI) and lead to acute respiratory distress syndrome (ARDS). Pulmonary surfactant (PS) plays a key role in a broad range of treatments for ARDS. The aim of the present investigation was to assess changes in the synthesis of phosphatidylcholine (PC) from choline and determine the effect of exogenous PS on its de novo synthesis in rats with OA-induced PE. Experimental rats were randomized into three groups, including a control group, OA-induced PE group, and OA-induced group treated with exogenous PS (OA-PS). Twenty-four rats were sacrificed 4 h after induction of the OA model, and tissue was examined by light and electron microscopy to assess the severity of ALI using an established scoring system at the end of the experiment. After 15 μCi 3H-choline chloride was injected intravenously, eight rats in each group were sacrificed at 4, 8, and 16 h. The radioactivity of 3H incorporated into total phospholipid (TPL) and desaturated phosphatidylcholine (DSPC) was measured in bronchoalveolar lavage fluid (BALF) and lung tissue (LT) using a liquid scintillation counter and was expressed as counts per minute (CPM). Results showed that TPL, DSPC, and the ratio of DSPC/total protein (TP) in lung tissue decreased 4 h after challenge with OA, but the levels recovered after 8 and 16 h. At 8 h after injection, 3H-TPL and 3H-DSPC radioactivity in the lungs reached its peak. Importantly, 3H-DSPC CPM were significantly lower in the PS treatment group (LT: Control: 62327 ± 9108; OA-PE: 97315 ± 10083; OA-PS: 45127 ± 10034, P < 0.05; BALF: Control: 7771 ± 1768; OA-PE: 8097 ± 1799; OA-PE: 3651 ± 1027, P < 0.05). Furthermore, DSPC secretory rate (SR) in the lungs was significantly lower in the PS treatment group at 4 h after injection (Control: 0.014 ± 0.003; OA-PE: 0.011 ± 0.004; OA-PS: 0.023 ± 0.006, P < 0.05). Therefore, we hypothesize that exogenous PS treatments may adversely affect endogenous de novo synthetic and secretory phospholipid pathways via feedback inhibition. This novel finding reveals the specific involvement of exogenous PS in endogenous synthetic and secretory phospholipid pathways during the treatment of ARDS. This information improves our understanding of how PS treatment is beneficial against ARDS and opens new opportunities for expanding its use.

Role of c-fos gene in vasoactive intestinal peptide promoted synthesis of pulmonary surfactant phospholipids.

Vasoactive Intestinal Peptide Induces Surfactant Protein A Expression In Atii Cells Through Activation Of Pkc/C-Fos Pathway

Effect of Vasoactive Intestinal Peptide on Pulmonary Surfactants Phospholipid Synthesis in Lung Explants

Role of c-fos gene in the pulmonary surfactant synthesis of cultured alveolar type II cells induced by endothelin-1

[Influence of Vasoactive Intestinal Peptide on Expression of Pulmonary Surfactant Associated Protein A in Lung Explants].

IgG Immune Complex-Induced Acute Lung Injury is Ameliorated by Camp Via Down-Regulation of C/EBP- and AP-1-mediated Transcriptions.

Effect of PP60c-Src on Ang Ⅱ- induced signal transduction in rat vascular smooth muscle cells

[Experiment Treatment of Collagen-Induced Arthritis in Rats with Recombinant Plasmid Containing Vasoactive Intestinal Peptide Gene].

[Effects of Vasoactive Intestinal Peptide on the Enzyme Activity of CTP: Phosphorylcholine Cytidylyltransferase from the Rat Lung].

Upregulation of Surfactant Synthesis Triggers ABCA1-mediated Basolateral Phospholipid Efflux.

Activation of CFTR trafficking and gating by vasoactive intestinal peptide in human bronchial epithelial cells.

Affection of Epidermal Growth Factor on VIP Secretion and VIPR Expression in Airway Epithelial Cells

Lipopolysaccharide activated phosphatidylcholine-specific phospholipase C and induced IL-8 and MCP-1 production in vascular endothelial cells.

Synthesis of phosphatidylcholine in rats with oleic acid-induced pulmonary edema and effect of exogenous pulmonary surfactant on its De Novo synthesis

MODULATION OF EPIDERMAL GROWTH FACTOR ON THE SYNTHESIS OF PULMONARY SURFACTANT AND ITS MECHANISM

Novel Role for Cystic Fibrosis Transmembrane Conductance Regulator in Alveolar Fluid Clearance in Lipopolysaccharide-Induced Acute Lung Injury in Mice.

Vasoactive Intestinal Peptide Inhibits the Activation of Murine Fibroblasts and Expression of Interleukin 17 Receptor C

Nitric Oxide-Induced Activation of NF–κB-mediated NMDA-induced CTP:phosphocholine Cytidylyltransferase Alpha Expression Inhibition in A549 Cells

Vasoactive intestinal peptide overexpression mediated by lentivirus attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting inflammation

Oxysterols Inhibit Phosphatidylcholine Synthesis Via Erk Docking and Phosphorylation of Ctp : Phosphocholine Cytidylyltransferase

Sphingosylphosphorylcholine Induces Α-Smooth Muscle Actin Expression in Human Lung Fibroblasts and Fibroblast-Mediated Gel Contraction Via S1P2 Receptor and Rho/Rho-kinase Pathway